Skip to main content

Table 2 WOMAC scores at M3 in patients receiving Phytalgic® and those receiving placebo

From: Phytalgic®, a food supplement, vs placebo in patients with osteoarthritis of the knee or hip: a randomised double-blind placebo-controlled clinical trial

  Phytalgic®
n = 41
Placebo
n = 40
Difference
Phytalgic® - Placebo
P
Pain     
   Mean (± std) 86.5 ± 94.3 235.3 ± 136.2 -148.8 ± 26.1 <0.001
   [95% CI] [56.2; 116.9] [194.2; 276.5] [-97.7; -199.9]  
Stiffness     
   Mean (± std) 41.4 ± 49.7 96.3 ± 71.0 -54.9 ± 13.8 <0.001
   [95% CI] [25.6; 57.2] [74.5; 118.2] [-27.9; -81.9]  
Function*     
   Mean (± std) 301.6 ± 315.6 746.5 ± 462.8 -444.8 ± 89.6 <0.001
   [95% CI] [200.1; 403.1] [603.1; 890.0] [-269.1; -620.4]  
Total*     
   Mean (± std) 430.1 ± 448.6 1085.4 ± 654.1 -655.2 ± 127.5 <0.001
   [95% CI] [285.0; 575.1] [882.0; 1288.9] [-405.4; -905.1]  
  1. *four patients with missing scores at baseline, M1, M2 and M3 (two patients in each group).